Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Allakos Inc. ALLK

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Siglec-8, an inhibitory receptor found on eosinophils and mast cells. In preclinical and clinical studies, AK002 has been shown to deplete eosinophils and inhibit mast cells.


Recent & Breaking News (NDAQ:ALLK)

4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm

ACCESSWIRE IA May 7, 2020

ALLK DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Allakos Inc. Investors of Class Action and Lead Plaintiff Deadline: May 11, 2020

GlobeNewswire May 7, 2020

Allakos Shareholder Notice: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm

Newsfile May 7, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK

GlobeNewswire May 7, 2020

MONDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile May 7, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Allakos (ALLK) Investors with Losses to Contact Its Attorneys: 5 DAY DEADLINE ALERT

ACCESSWIRE IA May 6, 2020

5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm

ACCESSWIRE IA May 6, 2020

ALLK INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Allakos Inc. Investors of Class Action and Lead Plaintiff Deadline: May 11, 2020

ACCESSWIRE IA May 6, 2020

ALLK INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors That Only 5 Days Remain to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Allakos Inc.

Business Wire May 6, 2020

MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile May 6, 2020

6-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses to Contact the Firm

ACCESSWIRE IA May 5, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allakos Inc. - ALLK

ACCESSWIRE IA May 5, 2020

Allakos Shareholder Notice: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm

Newsfile May 5, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Allakos (ALLK) Investors with Losses to Contact Its Attorneys: 7 DAY DEADLINE ALERT

ACCESSWIRE IA May 5, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Updates ALLK, CRON, FNKO Investors: 7-DAY APPLICATION DEADLINE ALERT, Investors with Losses Should Contact Firm

GlobeNewswire May 4, 2020

ALLK INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Allakos Inc. Investors of Class Action and Lead Plaintiff Deadline: May 11, 2020

ACCESSWIRE IA May 4, 2020

7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Allakos Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile May 4, 2020

Allakos Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Allakos Inc. To Contact The Firm

Newsfile May 4, 2020

Allakos Announces Positive Interim Results from an Open-Label Extension Study of Antolimab (AK002) in Patients with Eosinophilic Gastritis and/or Eosinophilic Duodenitis

GlobeNewswire May 4, 2020

ALLK DEADLINE: ROSEN, FIRST FILING AND TOP RANKED FIRM, Encourages Allakos Inc. Investors to Contact Firm Before Imminent Deadline in Class Action Seeking Recovery of Investor Losses - ALLK

ACCESSWIRE IA May 3, 2020